Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2015 Jul 26;1(2):111–121. doi: 10.1016/j.trci.2015.06.006

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2015 Eli Lilly and Company

This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).

PMC Copyright notice

Fig. S1 — Noninferiority statistics for early-start compared with delayed-start treatment groups for ADAS-Cog14, ADCS-iADL, CDR-SB, and MMSE among patients with mild AD in the solanezumab Expedition program through 3.5 years. Point estimates represent Δ₂–0.5Δ₁, and error bars represent the lower 90% confidence limit. Abbreviations: ADAS-Cog₁₄, 14-item Alzheimer's disease assessment scale–cognitive subscale; ADCS-iADL, Alzheimer's Disease Cooperative Study activities of daily living inventory, instrumental items; CDR-SB, clinical dementia rating scale–sum of boxes; MMSE, mini-mental status examination; AD, Alzheimer's disease.